Clearsynth is a leading innovator in pharmaceutical reference standards, offering high-quality Reference Standards for Neratinib, including both pharmacopeial and non-pharmacopeial impurities, metabolites, stable isotope products, and nitrosamines (N-NO products). Our Neratinib impurity reference standards are invaluable for pharmaceutical research, supporting product development, ANDA and DMF submissions, quality control (QC), method validation, and stability studies. They also aid in identifying unknown impurities and assessing genotoxic potential.
Our Neratinib-related products undergo thorough characterization and are supplied with detailed Certificates of Analysis (COA) and analytical data that meet regulatory requirements. All supplied products are re-tested at regular intervals to ensure ongoing quality and compliance.
Our Neratinib-related products undergo thorough characterization and are supplied with detailed Certificates of Analysis (COA) and analytical data that meet regulatory requirements. All supplied products are re-tested at regular intervals to ensure ongoing quality and compliance.
Neratinib Related Compounds
Stable Isotopes
| COMPOUND | CATEGORY | CAT. No. | CAS. No. | STOCK STATUS |
|---|---|---|---|---|
| Neratinib D6 | Stable Isotopes | CS-O-16870 | 1259519-18-0 | Enquire |
API Standards
| COMPOUND | CATEGORY | CAT. No. | CAS. No. | STOCK STATUS |
|---|---|---|---|---|
| Neratinib | API Standards | CS-T-59230 | 698387-09-6 | Enquire |
Metabolites
| COMPOUND | CATEGORY | CAT. No. | CAS. No. | STOCK STATUS |
|---|---|---|---|---|
| Neratinib dimethylamine N-oxide (M7) | Metabolites | CS-P-08337 | 1376615-55-2 | Enquire |
| Neratinib pyridine N-oxide (M3) | Metabolites | CS-P-08336 | 1376619-94-1 | Enquire |
| Neratinib quinoline N-oxide | Metabolites | CS-O-51244 | 1348481-03-7 | Enquire |
Impurities
| COMPOUND | CATEGORY | CAT. No. | CAS. No. | STOCK STATUS |
|---|---|---|---|---|
| Neratinib Bis-N-Oxide (M11) | Impurities | CS-O-57034 | Not Available | Enquire |
| Neratinib Impurity 1 | Impurities | CS-P-01845 | Not Available | Enquire |
| Neratinib Impurity 10 | Impurities | CS-P-01854 | 1144516-15-3 | Enquire |
| Neratinib Impurity 11 | Impurities | CS-P-01855 | Not Available | Enquire |
| Neratinib Impurity 12 | Impurities | CS-P-01856 | Not Available | Enquire |
| Neratinib Impurity 13 | Impurities | CS-P-01857 | Not Available | Enquire |
| Neratinib Impurity 2 | Impurities | CS-P-01846 | 1144516-20-0 | In Stock |
| Neratinib Impurity 3 | Impurities | CS-P-01847 | Not Available | Enquire |
| Neratinib Impurity 4 | Impurities | CS-P-01848 | Not Available | Enquire |
| Neratinib Impurity 5 | Impurities | CS-P-01849 | Not Available | In Stock |
| Neratinib Impurity 6 | Impurities | CS-P-01850 | Not Available | Enquire |
| Neratinib Impurity 7 | Impurities | CS-P-01851 | Not Available | Enquire |
| Neratinib Impurity 8 | Impurities | CS-P-01852 | Not Available | Enquire |
| Neratinib Impurity 9 | Impurities | CS-P-01853 | Not Available | Enquire |
| Neratinib methoxy impurity | Impurities | CS-O-33375 | Not Available | Enquire |
| Neratinib N-Methyl Impurity | Impurities | CS-O-33374 | 915788-27-1 | Enquire |
Intermediates
| COMPOUND | CATEGORY | CAT. No. | CAS. No. | STOCK STATUS |
|---|---|---|---|---|
| Neratinib maleate | Intermediates | CS-O-35952 | 915942-22-2 | Enquire |